The endogenous ratio of Smad2 and Smad3 influences the cytostatic function of Smad3

Molecular Biology of the Cell

Volumn 16, Issue 10, 2005, Pages 4672-4683

  Kim, Sang Gyun ^a   Kim, Hyun Ah ^a   Jong, Hyun Soon ^a   Park, Jung Hyun ^a   Kim, Noe Kyeong ^a   Hong, Seung Hwan ^b   Kim, Tae You ^a   Bang, Yung Jue ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CYCLIN DEPENDENT KINASE 2; LUCIFERASE; SMAD2 PROTEIN; SMAD3 PROTEIN; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL CYCLE; CELL LINE; CELL NUCLEUS; CELL PROLIFERATION; CELL TYPE; CONTROLLED STUDY; CYTOSTASIS; EPITHELIUM CELL; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PRIORITY JOURNAL; RNA INTERFERENCE; TRANSCRIPTION REGULATION;

ANIMALS; CELL CYCLE; CELL LINE; CELL PROLIFERATION; CYTOPLASM; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; GENES, REPORTER; HUMANS; MINK; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 26244439497     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E05-01-0054     Document Type: Article

References (55)

1. Attisano, L., and Wrana, J. L. (2002). Signal transduction by the TGF-β superfamily. Science 296, 1646-1647.
2. Chen, C. R., Kang, Y., Siegel, P. M., and Massagué, J. (2002). E2F4/5 and p107 as Smad cofactors linking the TGF-β receptor to c-myc repression. Cell 110, 19-32.
3. Claassen, G. F., and Hann, S. R. (2000). A role for transcriptional repression of p21CIP1 by c-Myc in overcoming transforming growth factor-β-induced cell-cycle arrest. Proc. Natl. Acad. Sci. USA 97, 9498-9503.
4. Datto, M. B., Frederick, J. P., Pan, L., Borton, A. J., Zhuang, Y., and Wang, X. F. (1999). Targeted disruption of Smad3 reveals an essential role in transforming growth factor-β-mediated signal transduction. Mol. Cell. Biol. 19, 2495-2504.
5. Datto, M. B., Li, Y., Panus, J. F., Howe, D. J., Xiong, Y., and Wang, X. F. (1995). Transforming growth factor-β induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc. Natl. Acad. Sci. USA 92, 5545-5549.
6. Derynck, R., Akhurst, R. J., and Balmain, A. (2001). TGF-β signaling in tumor suppression and cancer progression. Nat. Genet. 29, 117-129.
7. Derynck, R., Zhang, Y., and Feng, X. H. (1998). Smads: transcriptional activators of TGF-β responses. Cell 95, 737-740.
8. Dunn, N. R., Koonce, C. H., Anderson, D. C., Islam, A., Bikoff, E. K., and Robertson, E. J. (2005). Mice exclusively expressing the short isoform of Smad2 develop normally and are viable and fertile. Genes Dev. 19, 152-163.
9. Feng, X. H., Liang, Y. Y., Liang, M., Zhai, W., and Lin, X. (2002). Direct interaction of c-Myc with Smad2 and Smad3 to inhibit TGF-β-mediated induction of the CDK inhibitor p15(Ink4B). Mol. Cell 9, 133-143.
10. Feng, X. H., Lin, X., and Derynck, R. (2000). Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-β. EMBO J. 19, 5178-5193.
11. Frederick, J. P., Liberati, N. T., Waddell, D. S., Shi, Y., and Wang, X. F. (2004). Transforming growth factor-β-mediated transcriptional repression of c-myc is dependent on direct binding of Smad3 to a novel repressive Smad binding element. Mol. Cell. Biol. 24, 2546-2559.
12. Fujii, M., Takeda, K., Imamura, T., Aoki, H., Sampath, T. K., Enomoto, S., Kawabata, M., Kato, M., Ichijo, H., and Miyazono, K. (1999). Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblast and chondroblast differentiation. Mol. Biol. Cell 10, 3801-3813.
13. Han, S. U., Kim, H. T., Seong do, H., Kim, Y. S., Park, Y. S., Bang, Y. J., Yang, H. K., and Kim, S. J. (2004). Loss of the Smad3 expression increases susceptibility to tumorigenicity in human gastric cancer. Oncogene 23, 1333-1341.
14. Hannon, G. J., and Beach, D. (1994). p15INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature 371, 257-261.
15. Heldin, C. H., Miyazono, K., and ten Dijke, P. (1997). TGF-β signaling from cell membrane to nucleus through SMAD proteins. Nature 390, 465-471.
16. Izzi, L., and Attisano, L. (2004). Regulation of the TGF-β signaling pathway by ubiquitin-mediated degradation. Oncogene 23, 2071-2078.
17. Jong, H. S., Lee, H. S., Kim, T. Y., Im, Y. H., Park, J. W., Kim, N. K., and Bang, Y. J. (2002). Attenuation of transforming growth factor-β-induced growth inhibition in human hepatocellular carcinoma cell lines by cyclin D1 overexpression. Biochem. Biophys. Res. Commun. 292, 383-389.
18. Jonk, L. J., Itoh, S., Heldin, C. H., ten Dijke, P., and Kruijer, W. (1998). Identification and functional characterization of a Smad binding element (S.B.E) in the JunB. promoter that acts as a transforming growth factor-β, activin, and bone morphogenetic protein-inducible enhancer. J. Biol. Chem. 273, 21145-21152.
19. Kim, S. G., Jong, H. S., Kim, T. Y., Lee, J. W., Kim, N. K., Hong, S. H., and Bang, Y. J. (2004). Transforming growth factor-β1 induces apoptosis through Fas ligand-independent activation of the Fas death pathway in human gastric SNU-620 carcinoma cells. Mol. Biol. Cell 15, 420-434.
20. Kim, S. G., Kim, S. N., Jong, H. S., Kim, N. K., Hong, S. H., Kim, S. J., and Bang, Y. J. (2001). Caspase-mediated Cdk2 activation is a critical step to execute transforming growth factor-β1-induced apoptosis in human gastric cancer cells. Oncogene 20, 1254-1265.
21. Kim, S. J., Im, Y. H., Markowitz, S. D., and Bang, Y. J. (2000). Molecular mechanisms of inactivation of TGF-β receptors during carcinogenesis. Cytokine Growth Factor Rev. 11, 159-168.
22. Koff, A., Ohtsuki, M., Polyak, K., Roberts, J. M., and Massagué, J. (1993). Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-β. Science 260, 536-539.
23. Kretzschmar, M., Doody, J., Timokhina, I., and Massagué, J. (1999). A mechanism of repression of TGF-β/Smad signaling by oncogenic Ras. Genes Dev. 13, 804-816.
24. Labbe, E., Silvestri, C., Hoodless, P. A., Wrana, J. L., and Attisano, L. (1998). Smad2 and Smad3 positively and negatively regulate TGF-β-dependent transcription through the forkhead DNA-binding protein FAST2. Mol. Cell 2, 109-120.
25. Laiho, M., DeCaprio, J. A., Ludlow, J. W., Livingston, D. M., and Massagué, J. (1990). Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation. Cell 62, 175-185.
26. Lo, R. S., and Massagué, J. (1999). Ubiquitin-dependent degradation of TGF-β-activated smad2. Nat. Cell Biol. 1, 472-478.
27. Massagué, J., Blain, S. W., and Lo, R. S. (2000). TGF-β signaling in growth control, cancer, and heritable disorders. Cell 103, 295-309.
28. Massagué, J., and Wotton, D. (2000). Transcriptional control by the TGF-β/Smad signaling system. EMBO J. 19, 1745-1754.
29. Matsuura, I., Denissova, N. G., Wang, G., He, D., Long, J., and Liu, F. (2004). Cyclin-dependent kinases regulate the antiproliferative function of Smads. Nature 430, 226-231.
30. Miyazono, K. (2002). A new partner for inhibitory Smads. Cytokine Growth Factor Rev. 13, 7-9.
31. Moustakas, A., Pardali, K., Gaal, A., and Heldin, C. H. (2002). Mechanisms of TGF-β signaling in regulation of cell growth and differentiation. Immunol. Lett. 82, 85-91.
32. Moustakas, A., Souchelnytskyi, S., and Heldin, C. H. (2001). Smad regulation in TGF-β signal transduction. J. Cell Sci. 114, 4359-4369.
33. Nakao, A., et al. (1997). Identification of Smad7, a TGF-β-inducible antagonist of TGF-β signaling. Nature 389, 631-635.
34. Nicolas, F. J., and Hill, C. S. (2003). Attenuation of the TGF-β-Smad signaling pathway in pancreatic tumor cells confers resistance to TGF-β-induced growth arrest. Oncogene 22, 3698-3711.
35. Pardali, K., Kurisaki, A., Moren, A., ten Dijke, P., Kardassis, D., and Moustakas, A. (2000). Role of Smad proteins and transcription factor Sp1 in p21(Waf1/Cip1) regulation by transforming growth factor-β. J. Biol. Chem. 275, 29244-29256.
36. Park, J. H., Jung, Y., Kim, T. Y., Kim, S. G., Jong, H. S., Lee, J. W., Kim, D. K., Lee, J. S., Kim, N. K., and Bang, Y. J. (2004). Class I histone deacetylase-selective novel synthetic inhibitors potently inhibit human tumor proliferation. Clin. Cancer Res. 10, 5271-5281.
37. Piek, E., Ju, W. J., Heyer, J., Escalante-Alcalde, D., Stewart, C. L., Weinstein, M., Deng, C., Kucherlapati, R., Böttinger, E. P., and Roberts, A. B. (2001). Functional characterization of transforming growth factor-β signaling in Smad2- and Smad3-deficient fibroblasts. J. Biol. Chem. 276, 19945-19953.
38. Pietenpol, J. A., Stein, R. W., Moran, E., Yaciuk, P., Schlegel, R., Lyons, R. M., Pittelkow, M. R., Munger, K., Howley, P. M., and Moses, H. L. (1990). TGF-β1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains. Cell 61, 777-785.
39. Rich, J. N., Zhang, M., Datto, M. B., Bigner, D. D., and Wang, X. F. (1999). Transforming growth factor-β-mediated p15(INK4B) induction and growth inhibition in astrocytes is SMAD3-dependent and a pathway prominently altered in human glioma cell lines. J. Biol. Chem. 274, 35053-35058.
40. Seo, S. R., Lallemand, F., Ferrand, N., Pessah, M., L'Hoste, S., Camonis, J., and Atfi, A. (2004). The novel E3 ubiquitin ligase Tiul1 associates with TGIF to target Smad2 for degradation. EMBO J. 23, 3780-3792.
41. Seoane, J., Le, H. V., Shen, L., Anderson, S. A., and Massague, J. (2004). Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. Cell 117, 211-223.
42. Siegel, P. M., and Massagué, J. (2003). Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer. Nat. Rev. Cancer 3, 807-820.
43. ten Dijke, P., and Hill, C. S. (2004). New insights into TGF-β-Smad signaling. Trends Biochem. Sci. 29, 265-273.
44. ten Dijke, P., Miyazono, K., and Heldin, C. H. (1996). Signaling via hetero-oligomeric complexes of type I and type II serine/threonine kinase receptors. Curr. Opin. Cell Biol. 8, 139-145.
45. Tian, F., DaCosta Byfield, S., Parks, W. T., Yoo, S., Felici, A., Tang, B., Piek, E., Wakefield, L. M., and Roberts, A. B. (2003). Reduction in Smad2/3 signaling enhances tumorigenesis but suppresses metastasis of breast cancer cell lines. Cancer Res. 63, 8284-8292.
46. von Gersdorff, G., Susztak, K., Rezvani, F., Bitzer, M., Liang, D., and Böttinger, E. P. (2000). Smad3 and Smad4 mediate transcriptional activation of the human Smad7 promoter by transforming growth factor β. J. Biol. Chem. 275, 11320-11326.
47. Wakefield, L. M., and Roberts, A. B. (2002). TGF-β signaling: positive and negative effects on tumorigenesis. Curr. Opin. Genet. Dev. 12, 22-29.
48. Warner, B. J., Blain, S. W., Seoane, J., and Massagué, J. (1999). Myc down-regulation by transforming growth factor-β required for activation of the p15(Ink4b) G(1) arrest pathway. Mol. Cell. Biol. 19, 5913-5922.
49. Wolfraim, L. A., et al. (2004). Loss of Smad3 in acute T-cell lymphoblastic leukemia. N. Engl. J. Med. 351, 552-559.
50. Yagi, K., Goto, D., Hamamoto, T., Takenoshita, S., Kato, M., and Miyazono, K. (1999). Alternatively spliced variant of Smad2 lacking exon 3. Comparison with wild-type Smad2 and Smad3. J. Biol. Chem. 274, 703-709.
51. Yagi, K., Furuhashi, M., Aoki, H., Goto, D., Kuwano, H., Sugamura, K., Miyazono, K., and Kato, M. (2002). c-myc is a downstream target of the Smad pathway. J. Biol. Chem. 277, 854-861.
52. Yang, X., Letterio, J. J., Lechleider, R. J., Chen, L., Hayman, R., Gu, H., Roberts, A. B., and Deng, C. (1999). Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-β. EMBO J. 18, 1280-1291.
53. Yang, Y. C., Piek, E., Zavadil, J., Liang, D., Xie, D., Heyer, J., Pavlidis, P., Kucherlapati, R., Roberts, A. B., and Böttinger, E. P. (2003). Hierarchical model of gene regulation by transforming growth factor-β. Proc. Natl. Acad. Sci. USA 100, 10269-10274.
54. Zawel, L., Dai, J. L., Buckhaults, P., Zhou, S., Kinzler, K. W., Vogelstein, B., and Kern, S. E. (1998). Human Smad3 and Smad4 are sequence-specific transcription activators. Mol. Cell 1, 611-617.
55. Zhu, Y., Richardson, J. A., Parada, L. F., and Graff, J. M. (1998). Smad3 mutant mice develop metastatic colorectal cancer. Cell 94, 703-714.